Velox Design Lab · Shared design

Long-acting GH releaser

Research target: A growth-hormone-releasing peptide (GHRH analogue) with extended half-life.
GRF-Ext
90
✦ Likely brand-new
HADAIFTNSYRKVLG

A trimmed GHRH-analogue core with a glycine cap.

SomaPulse
91
✦ Likely brand-new
HADGIFTNSYRKVL

A variant probing position-4 tolerance.

PulseGH
85
✦ Likely brand-new
YADAIFTNSYRKVLA

An N-terminal Tyr variant for possible stability.

Design your own novel peptide free →
Closest compound you can order today
Tesamorelin
This brief points straight at Tesamorelin — the closest characterised compound Velox stocks for this kind of research.
Designed sequences are novel hypotheses that still have to be synthesised. Tesamorelin is real material you can study now — ≥99% HPLC-verified, batch Certificate of Analysis included, dispatched from the UK the next working day.
Research Tesamorelin →Browse related compounds →
Velox Design Lab outputs are computational sequence predictions for in vitro research use only. They are hypotheses, not validated compounds, and are not a medicinal product, not medical advice, and not for human or veterinary use. See our Research Use Policy.
Velox Design Lab outputs are computational predictions for in vitro research use only. Not validated compounds; not for human or veterinary use.
CRP Labs Ltd · NI738125 · About Design Lab · Research Use Policy